MarketPulse

biologics

16 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

65+ Pharma Giants Race to Dominate COPD Market with Next-Gen Biologics

Over 65 pharma companies advance 75+ COPD drugs, shifting from traditional bronchodilators to targeted biologics as AstraZeneca's tozorakimab validates new approaches.
AMGNPFESNYAZNUPB+2clinical trialsbiologics
BenzingaBenzinga··Nabaparna Bhattacharya

Amneal Pharmaceuticals Surges on $1.1B Kashiv Acquisition to Dominate Biosimilars

Amneal Pharmaceuticals surged 3.76% after agreeing to acquire Kashiv BioSciences for $1.1 billion, positioning itself in the $300 billion biosimilars market.
AMRXXPHASCEacquisitionstrategic partnership
BenzingaBenzinga··Na

Totaligent Acquires Aetherium Medical in Strategic Equity Deal to Expand Biotech Patient Access

Totaligent acquires Aetherium Medical platform in non-cash equity deal, gaining biotech infrastructure connecting innovators with Asia-Pacific patients for AI and regenerative therapies.
TGNTAsia-Pacificbiologics
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

90+ Companies Racing to Transform Psoriasis Treatment Landscape

Over 90 pharmaceutical companies are advancing 100+ psoriasis drugs through clinical trials, with major players like Takeda and Alumis posting positive Phase III results.
SNGXTAKFBLGCANFALMS+1clinical trialsbiologics
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Drug Development Services Market Set to Double to $50B by 2030

Drug development services market projected to reach $50.26B by 2030 from $28.09B in 2025, driven by AI adoption, personalized medicine, and emerging market expansion.
CRLIQVLZAGYLHWUXAYregulatory complianceclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Atopic Dermatitis Market to Triple to $21.5B by 2033, Driven by JAK Inhibitors

Atopic dermatitis drug market projected to grow from $8.5B (2023) to $21.5B (2033) at 9.8% CAGR, fueled by seven late-stage pipeline therapies.
PFEABBVLLYSNYREGNbiologicsatopic dermatitis
GlobeNewswire Inc.GlobeNewswire Inc.··Bcc Research

Life Sciences Validation Market Poised to Hit $3.9B by 2030 Amid Regulatory Push

Life sciences validation market projected to grow from $2.7B (2024) to $3.9B (2030) at 6.7% CAGR, driven by regulatory demands and digital transformation.
IBMTMODASTYSGSOYregulatory complianceIndustry 4.0
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Apogee Therapeutics Raises $350M via Public Offering to Fuel Biotech Pipeline

Apogee Therapeutics prices $350M offering at $70/share to fund development of inflammatory disease treatments, with lead candidate Zumilokibart targeting atopic dermatitis.
APGEclinical-stagepublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Apogee Therapeutics to Unveil 52-Week Phase 2 Data for APG777 Atopic Dermatitis Treatment

Apogee Therapeutics to present 52-week Phase 2 data for APG777 in atopic dermatitis on March 23, 2026, signaling major clinical development milestone.
APGEbiologicsatopic dermatitis
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Pharma Packaging Market to Surge 41% to $219B by 2031 on Injectable Boom

Global pharmaceutical packaging market projected to grow 41% from $154.78B in 2025 to $219.08B by 2031, driven by injectable drug demand and sustainability requirements.
GRRMYAMCRSWSHTPYATR+2regulatory compliancesustainability
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Cytokines Market Set to Nearly Double to $174.5B by 2032

Global cytokines market projected to grow from $95.32B (2025) to $174.53B (2032) at 9.02% CAGR, driven by manufacturing advances and strategic partnerships.
AMGNBMYCELGrJNJMRK+6strategic partnershipssupply chain resilience
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Packaging

U.S. Clinical Trial Packaging Market Set to Nearly Triple by 2035

U.S. clinical trial packaging market expected to nearly triple to $2.7 billion by 2035, driven by increased R&D spending and demand for advanced, specialized packaging solutions.
AMCRsustainable packagingclinical trial packaging
BenzingaBenzinga··Globe Newswire

Totaligent Secures Joint Venture with GloMed Solutions, Establishes Acquisition Path

Totaligent secures joint venture with Japanese medical distributor GloMed Solutions, with option to acquire full ownership within one year, expanding into high-growth aesthetics market.
TGNTAEMDacquisitionmedical aesthetics
GlobeNewswire Inc.GlobeNewswire Inc.··Visiongain

Ophthalmic Drug Market to Reach $41.88B by 2026 Amid Innovation Wave

Global ophthalmic drug market projected to reach $41.88B by 2026, growing 7.9% annually driven by biologic therapies, advanced delivery systems, and AI-enabled diagnostics.
PFEABBVNVSALCRHHBY+3AMDbiologics
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Packaging

Pharmaceutical Glass Packaging Market Poised to Double by 2035

Pharmaceutical glass packaging market expected to nearly double from $5.32B in 2025 to $12.39B by 2035, driven by injectable drugs, biologics, and stricter EU regulations.
OIGRRMYSHTPYSTVNATRsustainabilitybiologics
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Biopharmaceutical CMO Market Set to Quadruple to $76.2B by 2035

Biopharmaceutical CMO market to grow from $21.16B in 2025 to $76.2B by 2035, driven by outsourcing demand and capacity constraints.
TMOLZAGYWXXWYbiologicsmonoclonal antibodies